Is it okay to apologize by email instead of a call?

Email is fine for operational misses and creates a record of the fix. If you embarrassed them in front of their team or blew a customer moment, call first and follow with a written recap. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Is it weird to email someone after six months of silence?

Not if you have a new reason and you don't pretend the old thread is still warm. Lead with the trigger, remind them who you are in one line, and make the ask optional. Nostalgia without news is just another cold email with extra steps.

Is it okay to send this apology on LinkedIn instead of email?

Yes if this CTO is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals apology?

Don't use consumer-startup slang. It's a credibility leak. Calling it 'AI-powered' with no description of the system. Don't open with 'it's been a while' and then paste the old pitch. Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Can I use aggressive sales language in pharma outreach?

No. Unapproved claims, off-label hints, and fake urgency can create real problems. Be operational: timelines, review status, access, meeting logistics. Save clinical discussion for approved materials and the right role. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Pharmaceuticals · CTO · Long Time No Contact

Apology for Pharmaceuticals CTO: Long Time No Contact

A apology email for a Pharmaceuticals CTO (long time no contact) is a short message that reopens the thread without making them do extra work. An apology email names the miss, owns it without excuses, states the fix, and tells them what changes so it doesn't happen again. In this setting, that means speaking to follow-up that ignores MLR, off-label

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this apology work for a Pharmaceuticals CTO?

Name the miss in plain language.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a CTO actually reads: 90 words is plenty if the substance is real. Don't pad.
Bring a new observation about their world, then offer a small, optional next step.
Pair the apology with an owned fix and a time.

When should I send this to a Pharmaceuticals CTO?

Send it as soon as you know you were wrong. Delay makes it look calculated. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a CTO, 90 words is plenty if the substance is real. Don't pad.

What this CTO actually cares about

A CTO in Pharmaceuticals is protecting reliability, security, and engineering time. They look for architecture, failure modes, and whether you'll create toil for their team. Fluff is a ranking signal that you don't know the work. The hook that earns a look is an incident class, a security gap, or a cost line they already hate. The ask should stay at this size: a technical working session or a written teardown, not a 'vision call'. Delete trigger: Calling it 'AI-powered' with no description of the system. They look for architecture, failure modes, and whether you'll create toil for their team. Fluff is a ranking signal that you don't know the work.

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Launch calendars and review boards set speed. You don't. Words that work: MLR, label, access, HCP, congress, promotional review.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone precise.
Follow through or the email becomes evidence you talk and don't do.
Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this long time no contact note?

If you explain more than you apologize, it's not an apology.
Don't open with 'it's been a while' and then paste the old pitch.
Don't use consumer-startup slang. It's a credibility leak.
Calling it 'AI-powered' with no description of the system.

How does this long time no contact scenario compare?

Dimension	For this template
Best send window	Only when you have a trigger
Ideal length	90 words is plenty if the substance is real. Don't pad.
Primary ask	a technical working session or a written teardown, not a 'vision call'
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Precise. No slogans. It's fine to be a little dry.
Unlike no response	This isn't a 4-day bump. It's a re-introduction with a new reason.
Unlike breakup	You're opening a door, not closing one. Still keep it easy to ignore.

What should I copy and send?

Copy-ready template

Subject

Pharmaceuticals note on follow-up that ignores MLR, off-label risk,

Body

Hi [First Name],

You should have had [thing] by [time]. You didn't. That's my fault.

In Pharmaceuticals, that usually shows up as follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. If this cost you [meeting / deadline / money], tell me how you want us to make it right.

Given this is long time no contact, ask if the old problem still exists, or if you should leave it archived.

What do you need from me today?

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Send it as soon as you know you were wrong. Delay makes it look calculated. Send when you have a real trigger: news, a useful artifact, a role change, a season. After that, send a breakup note and archive it. A CTO who wants it will answer a clean close more often than a fifth bump.

Related templates

Want a custom draft instead? Try the email generator.